Mogrify

Transforming the development of life saving cell therapies via the licence of proprietary cell conversions tailored to any therapeutic application.

Launch date

Feb 2016

Employees

Market cap

Net debt

-

Enterprise valuation

$85m (Public information from Oct 2023)

Company register number 10002103

Cambridge England (HQ)

https://mogrify.co.uk

https://twitter.com/mogrify_uk https://www.linkedin.com/company/mogrify-developing-next-generation-cell-therapies

View job openings

Authorizing premium user...